Effect of Serum Leptin on Weight Gain Induced by Olanzapine in Female Patients with Schizophrenia.

Effect of Serum Leptin on Weight Gain Induced by Olanzapine in Female Patients with Schizophrenia.

Olanzapine (OLZ) treatment is associated with a high risk of weight gain, and may cause abnormalities in glycolipid metabolism. Therefore, the underlying mechanism of OLZ-related weight gain is needed to clarify but not yet been adequately determined. In recent years, adipocytokines such as leptin,...

Full description

Bibliographic Details
Main Authors:	Nobuto Tsuneyama, Yutaro Suzuki, Kazushi Sawamura, Takuro Sugai, Naoki Fukui, Junzo Watanabe, Shin Ono, Mami Saito, Toshiyuki Someya
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2016-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4773092?pdf=render

Similar Items

Effects of olanzapine on resting heart rate in Japanese patients with schizophrenia.
by: Misuzu Tajiri, et al.
Published: (2018-01-01)

Serum cortisol and insulin-like growth factor 1 levels in major depressive disorder and schizophrenia
by: Hiroshi Arinami, et al.
Published: (2023-01-01)

Psychiatrists' attitudes toward metabolic adverse events in patients with schizophrenia.
by: Norio Sugawara, et al.
Published: (2014-01-01)

Worth the Weight? Olanzapine Prescribing in Schizophrenia. A Review of Weight Gain and Other Cardiometabolic Side Effects of Olanzapine
by: Ita Fitzgerald, et al.
Published: (2021-09-01)

Topiramate Adjunctive Therapy for Olanzapine Induced Weight Gain in Patients with Schizophrenia
by: Sanjib Pandit, et al.
Published: (2019-08-01)

Treatment progress of weight gain and abnormal lipid metabolism in patients with schizophrenia caused by clozapine and olanzapine
by: Kang Li, et al.
Published: (2021-04-01)

High-density lipoprotein-cholesterol and antipsychotic medication in overweight inpatients with schizophrenia: post-hoc analysis of a Japanese nationwide survey
by: Shin Ono, et al.
Published: (2018-06-01)

Reversal of olanzapine-induced weight gain in a patient with schizophrenia by switching to asenapine: a case report
by: Okazaki K, et al.
Published: (2017-11-01)

Early evaluation of patient risk for substantial weight gain during olanzapine treatment for schizophrenia, schizophreniform, or schizoaffective disorder
by: Hardy Thomas A, et al.
Published: (2008-09-01)

Increased Appetite Plays a Key Role in Olanzapine-Induced Weight Gain in First-Episode Schizophrenia Patients
by: Jing Huang, et al.
Published: (2020-05-01)

Relationship Between Plasma Olanzapine and N-Desmethyl-Olanzapine Concentration and Metabolic Parameters in Patients With Schizophrenia
by: Huimei An, et al.
Published: (2022-06-01)

Application of Plasma Levels of Olanzapine and N-Desmethyl-Olanzapine to Monitor Clinical Efficacy in Patients with Schizophrenia.
by: Mong-Liang Lu, et al.
Published: (2016-01-01)

High Prevalence of Obesity, Hypertension, Hyperlipidemia, and Diabetes Mellitus in Japanese Outpatients with Schizophrenia: A Nationwide Survey.
by: Takuro Sugai, et al.
Published: (2016-01-01)

Exclusive Breastfeeding Is Not Associated with Maternal–Infant Bonding in Early Postpartum, Considering Depression, Anxiety, and Parity
by: Naoki Fukui, et al.
Published: (2021-04-01)

Olanzapine- induced metabolic syndrome pathogenesis: Hypothalamic “leptin resistance” or “pomc resistance”?
by: F. Veneziani, et al.
Published: (2021-04-01)

Corrigendum: Increased Appetite Plays a Key Role in Olanzapine-Induced Weight Gain in First-Episode Schizophrenia Patients
by: Jing Huang, et al.
Published: (2020-06-01)

Effectiveness and safety of olanzapine in the treatment of Asian outpatients with schizophrenia
by: Habil, H., et al.
Published: (2007)

Association Between the Number of Remaining Teeth and Body Mass Index in Japanese Inpatients with Schizophrenia
by: Otake M, et al.
Published: (2022-11-01)

Comparison of olanzapine-induced weight gain and metabolism abnormalities between topiramate and vitamin C in patients with schizophrenia: a preliminary study
by: Jinling Zhang, et al.
Published: (2023-05-01)

Metformin and berberine prevent olanzapine-induced weight gain in rats.
by: Yueshan Hu, et al.
Published: (2014-01-01)

Preventing olanzapine-induced weight gain using betahistine: a study in a rat model with chronic olanzapine treatment.
by: Jiamei Lian, et al.
Published: (2014-01-01)

Subcutaneous Olanzapine at the End of Life in a Patient with Schizophrenia and Dysphagia
by: Jonathan Hindmarsh, et al.
Published: (2020-06-01)

Olanzapine-Samidorphan for Schizophrenia: A Systematic Review and Meta-Analysis
by: Dhyuti Gupta, et al.
Published: (2024-01-01)

Effects of olanzapine on anhedonia in schizophrenia: mediated by complement factor H
by: Yi Zhang, et al.
Published: (2023-07-01)

Change in level of productivity in the treatment of schizophrenia with olanzapine or other antipsychotics
by: Osuntokun Olawale, et al.
Published: (2011-05-01)

A naturalistic comparison of the efficacy and safety of intramuscular olanzapine and intramuscular levomepromazine in agitated elderly patients with schizophrenia
by: Suzuki H, et al.
Published: (2013-08-01)

Whole-brain Transcriptomic Analysis of Weight Gain Mice induced by Olanzapine
by: ZHANG Yuan, et al.
Published: (2023-06-01)

Longitudinal Gut Microbiota Dysbiosis Underlies Olanzapine-Induced Weight Gain
by: Li Qian, et al.
Published: (2023-08-01)

The antipsychotic olanzapine interacts with the gut microbiome to cause weight gain in mouse.
by: Andrew P Morgan, et al.
Published: (2014-01-01)

Treatment with olanzapine, risperidone or typical antipsychotic drugs in Asian patients with schizophrenia
by: Lee, C., et al.
Published: (2006)

Effect of Co-Treatment of Olanzapine with SEP-363856 in Mice Models of Schizophrenia
by: Lingzhi Liang, et al.
Published: (2022-04-01)

Effect of Haloperidol and Olanzapine on Hippocampal Cells’ Proliferation in Animal Model of Schizophrenia
by: Jana Osacka, et al.
Published: (2022-07-01)

High-dose olanzapine in treatment-resistant schizophrenia: a systematic review
by: Louisa Gannon, et al.
Published: (2023-05-01)

Olanzapine versus typical neuroleptics for schizophrenia: evaluation of social and economic costs
by: Giorgio Mariani, et al.
Published: (2006-09-01)

A commentary on the efficacy of olanzapine for the treatment of schizophrenia: the past, present, and future
by: Citrome L, et al.
Published: (2019-09-01)

Genetic Association of Olanzapine Treatment Response in Han Chinese Schizophrenia Patients
by: Wei Zhou, et al.
Published: (2019-03-01)

Cost/effectiveness of aripiprazole vs. olanzapine in the long-term treatment of schizophrenia
by: Dutina Aleksandra, et al.
Published: (2019-01-01)

Opioid antagonists to prevent olanzapine-induced weight gain: A systematic review
by: S. Andrea Laguado, PharmD, BCPS, BCPP, et al.
Published: (2023-08-01)

The Role of the Central and the Peripheral Neuropeptides in Weight Gain and Metabolic Changes Related to Olanzapine
by: Nazile Arpaci, et al.
Published: (2021-03-01)

Alterations to melanocortinergic, GABAergic and cannabinoid neurotransmission associated with olanzapine-induced weight gain.
by: Katrina Weston-Green, et al.
Published: (2012-01-01)